STREAMEX CORP. Share-based Payment Arrangement, Expense
STREAMEX CORP. (STEX) reported Share-based Payment Arrangement, Expense of $3.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- STREAMEX CORP. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.95M, a 26.39% decline year-over-year.
- STREAMEX CORP. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $25.37M, a 1123.24% increase year-over-year.
- STREAMEX CORP. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $48.82M.
- STREAMEX CORP. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $842.00K, a 44.50% decline year-over-year.
- STREAMEX CORP. share-based payment arrangement, expense for fiscal 2025 was $57.10M, a 720.81% increase from fiscal 2024.
- STREAMEX CORP. share-based payment arrangement, expense for fiscal 2024 was $6.96M, a 12.80% decline from fiscal 2023.
- STREAMEX CORP. share-based payment arrangement, expense for fiscal 2023 was $7.98M, a 80.83% increase from fiscal 2022.
- STREAMEX CORP. share-based payment arrangement, expense for fiscal 2022 was $4.41M, a 53.56% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.95M 10-Q · filed 2026-08-14 | $7.86M 10-Q · filed 2026-08-14 | $78.14M derived: sum of 3 quarters · filed 2026-08-14 | $78.98M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $25.37M 10-Q · filed 2026-05-14 | $74.19M derived: sum of 2 quarters · filed 2026-05-14 | $75.03M derived: sum of 3 quarters · filed 2026-05-14 | $80.40M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-12-31 | $48.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $49.66M derived: sum of 2 quarters · filed 2026-03-31 | $55.03M derived: sum of 3 quarters · filed 2026-03-31 | $57.10M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $842.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.21M derived: sum of 2 quarters · filed 2025-11-14 | $8.29M 10-Q · filed 2025-11-14 | $8.23M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $7.44M 10-Q · filed 2025-08-15 | $7.39M derived: sum of 3 quarters · filed 2026-05-14 | $8.91M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-03-31 | $2.07M 10-Q · filed 2026-05-14 | $2.02M derived: sum of 2 quarters · filed 2026-05-14 | $3.54M derived: sum of 3 quarters · filed 2026-05-14 | $7.97M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.46M derived: sum of 2 quarters · filed 2026-03-31 | $5.90M derived: sum of 3 quarters · filed 2026-03-31 | $6.96M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.95M derived: sum of 2 quarters · filed 2025-11-14 | $7.01M 10-Q · filed 2025-11-14 | $8.46M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $5.49M 10-Q · filed 2025-08-15 | $6.94M derived: sum of 3 quarters · filed 2025-08-15 | $6.58M derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-19 | $2.51M derived: sum of 2 quarters · filed 2025-05-19 | $2.15M derived: sum of 3 quarters · filed 2025-05-19 | $6.89M derived: sum of 4 quarters · filed 2025-05-19 | ||
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.09M derived: sum of 2 quarters · filed 2025-04-15 | $5.83M derived: sum of 3 quarters · filed 2025-04-15 | $7.98M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | -$359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.38M derived: sum of 2 quarters · filed 2024-11-14 | $6.53M 10-Q · filed 2024-11-14 | $8.24M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $6.89M 10-Q · filed 2024-08-14 | $8.60M derived: sum of 3 quarters · filed 2024-08-14 | $9.14M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $2.15M 10-Q · filed 2024-05-20 | $3.86M derived: sum of 2 quarters · filed 2024-05-20 | $4.39M derived: sum of 3 quarters · filed 2024-05-20 | $4.56M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $2.25M derived: sum of 2 quarters · filed 2024-04-16 | $2.41M derived: sum of 3 quarters · filed 2024-04-16 | $4.41M 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $537.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $703.00K derived: sum of 2 quarters · filed 2023-11-14 | $2.70M 10-Q · filed 2023-11-14 | $5.59M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.17M 10-Q · filed 2023-08-14 | $5.05M derived: sum of 3 quarters · filed 2023-08-14 | $7.36M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-15 | $4.89M derived: sum of 2 quarters · filed 2023-05-15 | $7.19M derived: sum of 3 quarters · filed 2023-05-15 | $8.98M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.19M derived: sum of 2 quarters · filed 2023-03-31 | $6.98M derived: sum of 3 quarters · filed 2023-03-31 | $9.50M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.09M derived: sum of 2 quarters · filed 2022-11-14 | $6.61M 10-Q · filed 2022-11-14 | $11.21M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $4.31M 10-Q · filed 2022-08-15 | $8.90M derived: sum of 3 quarters · filed 2022-08-15 | $13.73M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $2.52M 10-Q · filed 2022-05-16 | $7.11M derived: sum of 2 quarters · filed 2022-05-16 | $11.94M derived: sum of 3 quarters · filed 2022-05-16 | $23.27M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $9.42M derived: sum of 2 quarters · filed 2022-03-31 | $20.75M derived: sum of 3 quarters · filed 2022-03-31 | $25.16M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $16.16M derived: sum of 2 quarters · filed 2021-11-15 | $20.57M 10-Q · filed 2021-11-15 | $20.57M 10-Q · filed 2020-11-05 | $28.05M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $11.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $15.74M 10-Q · filed 2021-08-11 | $15.74M 10-Q · filed 2020-08-06 | $23.23M derived: sum of 3 quarters · filed 2021-08-11 | $25.20M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $4.41M 10-Q · filed 2021-05-17 | $11.89M derived: sum of 2 quarters · filed 2021-05-17 | $13.86M derived: sum of 3 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $9.45M derived: sum of 2 quarters · filed 2021-03-15 | $15.18M 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.70M 10-Q · filed 2020-11-05 | $501.00K 10-Q · filed 2019-10-23 | |||
| 2019-06-30 | $5.73M 10-Q · filed 2020-08-06 | $2.27M 10-Q · filed 2019-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |